Document is current

Article History

Received: 22 November 2024

Accepted: 29 January 2025

First Online: 19 March 2025

Declarations

:

: The study was approved by the Health Ethics Research Board at Advarra.

: Not applicable.

: PKK: has been a speaker, advisory board member, or consultant for and has received honoraria from ALK- Abelló, AstraZeneca, Bausch, Bayer, BioCryst Pharmaceuticals, Canadian Agency for Drugs and Technologies in Health (CADTH), Canadian Pharmacists Association (CPA), CSL Behring, GSK, Medexus Pharmaceuticals Inc., Merck & Co., Novartis, Sanofi Genzyme, Takeda/Shire, and Valeo; has received research grants from CSL Behring and Takeda/Shire; serves as a medical advisor (volunteer) for Hereditary Angioedema Canada, a patient organisation; serves as a board member (volunteer) for the Canadian Hereditary Angioedema Network (CHAEN), a physician organisation; and is an employee of McMaster University; GL: has received consultancy and speaker fees from Takeda, CSL Behring, and consultancy fees from BioCryst, KalVista, and is a member of CHAEN; DG: has consulted and participated in advisory boards and has received honoraria from BioCryst, CSL Behring, and Takeda; SDB: has consulted and participated in advisory boards for ALK, Astria, BioCryst Pharmaceuticals, Canadian Blood Services, CSL Behring, Ionis Pharmaceuticals, KalVista Pharma, Pharming, Pharvaris, Takeda, WSIB; has received speaker’s honoraria from CSL Behring, Biocryst Pharmaceuticals, Novartis, and Takeda; and has received research funding from the Canadian Institutes of Health Research (CIHR), the Canadian Immunization Research Network (CIRN), CSL Behring, and Takeda; BY, MFD, NT, RES: are employees of Cencora, Innomar Strategies, Inc; MM, HM, AM: are employees of CSL Behring Canada Inc.; SW: has received grants and research support from AllerGen, the Canadian Allergy, Asthma, and Immunology Foundation (CAAIF), and ALK-Abelló; speaker’s bureau/honoraria and consulting fees from GSK, Merck & Co. Canada, Novartis, CSL Behring, Pfizer Canada, Sanofi Canada, AZ, Takeda, Teva, Pediapharma (Medexus), Mylan, AbbVie, Sanofi, Aimmune, Regeneron, Aralez (Miravohealth), Bausch Lomb, Avir Pharma; serves on the Scientific Advisory Committee on Respiratory and Allergy Therapies (Health Canada), with Food Allergy Canada, Asthma Canada, board of directors with CHAEN, and the Allergy Asthma & Immunology Society of Ontario (AAISO).